Arterra Bioscience SpAMIL: ARBS

ARBS: Strong profit growth and R&D advances support a positive outlook and dividend proposal

· Issued by Arterra Bioscience SpA

Production value and net profit grew strongly year-over-year, driven by a surge in cosmetic raw material sales and robust R&D activity. Financial position remains solid, with optimism for continued growth in 2025 and a proposed dividend of €0.13 per share.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Arterra Bioscience SpA on 6ix

Earlier from Arterra Bioscience

Later from Arterra Bioscience

All Arterra Bioscience news releases